Brilliant Violet 750TM anti-human CD4 [SK3] and 3 more items

The University of Virginia awarded a contract to BioLegend Inc. on June 12, 2026, for the procurement of specialized flow cytometry reagents. The contract, valued at $935, encompasses four distinct monoclonal antibody products designed for human cell surface antigen detection. The line items include Brilliant Violet 750 anti-human CD4 [SK3] at $313.50, APC/Fire 750 anti-human CD197 (CCR7) [G043H7] at $267.40, Brilliant Violet 570 anti-human CD27 [O323] at $169.50, and Pacific Blue anti-human CD16 [3G8] at $184.80. All materials are being delivered to Glenda Canderan at the University of Virginia in Virginia.

The contract represents a small purchase order for research-grade immunological reagents used in flow cytometric analysis applications. Each of the four monoclonal antibody products is being procured in a quantity of one unit. These reagents are typically employed in biomedical research settings for lymphocyte characterization and immune cell phenotyping. The Virginia-based contracting organization has selected BioLegend Inc. as the prime contractor to supply these specialized laboratory products.